KMT2A and leukemia: CRISPR/Cas9-mediated sgRNA competition assays demonstrated that Kat7/KAT7 (the gene encoding HBO1) is required for the proliferation of various MLL fusion-ICs (Figure 2F) and in human leukemia cell lines (Figure 2—figure supplement 3B).